Table 1.
Patient demographics and clinical characteristics within ependymoma and pilocytic astrocytoma tumor patient cohorts
| Ependymomas | Pilocytic astrocytomas | |
|---|---|---|
| Patients | 88 | 80 |
| Male | 48 | 42 |
| Female | 40 | 38 |
| Age (years) | ||
| Median (Mean ± SD) | 37 (35 ± 21) | 9 (14 ± 14) |
| Minimum | 1 | 0 |
| Maximum | 73 | 58 |
| Follow-up for primary tumor patients | ||
| Survivors in the end of the follow-up | 60 | 69 |
| Follow-up time for survivors (m) (median (mean ± SD)) | 125 (135 ± 82) | 70 (111 ± 89) |
| 5-year residive-free survival (%) | 71 | 82 |
| 5-year survival (%) | 82 | 93 |
| Tumors | 108 | 80 |
| Primary | 74 | 73 |
| Second | 14 | 5 |
| Third | 14 | 1 |
| Fourth-sixth | 6 | 1 |
| Histological grade | ||
| I | 18 | 80 |
| II | 68 | 0 |
| III | 22 | 0 |
| Topography | ||
| Supratentorial | 35 | 3 |
| Infratentorial | 28 | 69 |
| Spinal | 43 | 2 |
| Cranial nerve | 0 | 6 |
Patient age and follow-up information were calculated using primary cases. Follow-up times are shown in months (m)
SD standard deviation